Childhood Acute Megakaryocytic Leukemia (M7) Completed Phase 2 Trials for Cyclophosphamide (DB00531)

IndicationStatusPhase
DBCOND0028563 (Childhood Acute Megakaryocytic Leukemia (M7))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01093586Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesTreatment
NCT01427881Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological MalignanciesTreatment
NCT01177371High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin LymphomaTreatment